Drug Manufacturers – Major Volume Active Stocks: Pfizer Inc. (NYSE FE), Keryx Biopharmaceuticals (NASDAQ:KERX), (NYSE:MRK), (NYSE:ABT)

By FastMovingStock.com

on 30/01/2013

NEW YORK, JANUARY 30, 2013 — (Net PR News) – Pfizer Inc. (NYSE FE) moved up +3.20% and closed at the end of the trading day at $27.70. The stock showed upbeat weekly, monthly and quarterly performance of +3.82%, +10.18% and +10.45%, respectively. The Institutional Ownership remained 72.92%. PFE was among the Drug Manufacturing industry volume active stocks and traded 75,998,400 shares on Tuesday.

Pfizer Inc. (NYSE FE) has uncovered Q4 and full year 2012 financial results and for Q4 the revenues were totaled $15.1 billion, down -7% evaluated against $16.1 billion in the Q4 of 2011 , which represents an operational turn down of $802 million, or 5%, and the adverse impact of foreign exchange of $271 million.

Get A Free Report And Detailed Analysis On PFE CLICK HERE To Read

Keryx Biopharmaceuticals (NASDAQ:KERX) traded with volume of 60.21 million shares in the last session, as compared to average volume of 4.04 million shares. The stock showed upbeat weekly, monthly and quarterly performances of +148.81%, +222.78% and +225.29%, respectively. The yearly and YTD trends of the stock were +173.20% and +219.08%, respectively.

Is KERX A Solid Investment At These Levels? Find Out Exactly Where KERX Is Headed With This TREND ANALYSIS REPORT

Merck & Co., Inc. (NYSE:MRK) was a positive trend taker in its yesterday’s trade and showed a bullish movement of +1.70%. On January 29, 2013, the stock, after opening at $43.19, gained the high price range in the previous trading day of $43.74 and then closed at $43.66. Market capitalization of MRK was 132.73 billion. MRK was a gainer in its 5 days and one month’s performance as shown by graph, it moved positively +1.06% and +7.43%, respectively.

How Should Investors React To MRK Now? Find Out In This TREND ANALYSIS REPORT

Abbott Laboratories (NYSE:ABT) started the session at $32.97, traded in the day range of $32.96 – $33.45 and closed the trading at $33.33. ABT traded 14.64 million shares and its average volume was 11.85 million shares. The 52 week range of the stock was $31.64 – $72.47. Weekly, monthly and quarterly trends of the stock were +1.31%, +7.48% and +6.66%, respectively. Abbott Laboratories (NYSE:ABT) has updated the financial results of Q4 ended Dec. 31, 2012. Q4 diluted EPS, exclusive of specified items, were $1.51. Diluted EPS under GAAP were $0.66, together with specified items.

How Should Investors Trade ABT Now? Don’t Trade ABT Until You Read This TREND ANALYSIS REPORT

About Fast Moving Stocks

FastMovingStock.com is engaged in providing valuable ideas and news information on U.S. stocks on a regular basis. FastMovingStock.com provides detailed research guides on small cap and large cap stocks, helping investors in making wise stock market investment decisions through its free e-newsletter to subscribers.

Disclaimer:

The assembled information disseminated by fastmovingstock.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Fast moving stock.com does not expect that investors will buy and sell securities based on information assembled and presented in fastmovingstock.com. PLEASE always do your own due diligence, and consult your financial advisor.